Loading market dashboard
Aprea Therapeutics, Inc.
APREHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Aprea Therapeutics, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $66.65M | $66.65M - $66.65M | $13.33M | $0.255 | 3 |
| Dec 2029 | $12.21M | $12.21M - $12.21M | $2.44M | -$0.475 | 3 |
| Dec 2028 | $4.02M | $4.02M - $4.02M | $804.3K | -$0.73 | 4 |
| Dec 2027 | $2.26M | $2.26M - $2.26M | $452.6K | -$0.653 | 3 |
| Dec 2026 | $1.07M | $1.07M - $1.07M | $214.0K | -$0.683 | 3 |
| Dec 2025 | $293.7K | $283.5K - $303.8K | $58.7K | -$1.99 | 2 |
| Dec 2024 | $1.34M | $1.12M - $1.55M | $267.7K | -$2.51 | 2 |
| Dec 2023 | $1.28M | $1.28M - $1.28M | $255.1K | -$2.936 | 1 |
| Dec 2022 | $249.7K | $249.7K - $249.7K | $49.9K | -$72.70 | 1 |